Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Opposite effects of different doses of MCSF on ERK phosphorylation and cell proliferation in macrophages

Abstract

We had previously shown that murine macrophages expressing v-Fes, the oncogenically activated counterpart of the c-Fes cytoplasmic tyrosine kinase, proliferate independently of Macrophage Colony-Stimulating Factor (MCSF) and that the Extracellular signal-Regulated Kinase (ERK) pathway mediates the mitogenic effect of v-Fes. In this study, the response of c-fes- and v-fes-overexpressing cells to MCSF was investigated. A critical modulation of the activation of Mitogen-activated ERK Kinase (MEK) and ERK based on the MCSF dose was characterized. ERK activation was increased by MCSF doses capable to elicit a mitogenic response (2–5 U/ml). On the contrary, MCSF doses as low as 0.05 U/ml markedly reduced ERK phosphorylation and nuclear content and moderately but significantly reduced cell proliferation. The reduction of MEK and ERK phosphorylation was very rapid, suggesting the involvement of cytosolic phosphatases. Among these, phospho–tyrosine protein phosphatases and phosphoserine/threonine protein phosphatase-2A were found involved. These findings represent the first observation that different doses of the same growth factor, MCSF in particular, can exert opposite effects on cell proliferation by switching on or off ERK signaling.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Alessi D-R, Gomez N, Moorhead G, Lewis T, Keyse S-M, Cohen P . 1995 Curr. Biol. 5: 283–295

  • Anderson N-G, Maller J-L, Tonks N-K, Sturgill T-W . 1990 Nature 343: 651–653

  • Areces L-B, Dello Sbarba P, Jücker M, Stanley E-R, Feldman R . 1994 Mol. Cell Biol. 14: 4606–4615

  • Büscher D, Dello Sbarba P, Hipsking R-A, Rapp U-R, Stanley E-R, Baccarini M . 1993 Oncogene 8: 3323–3332

  • Büscher D, Hipsking R-A, Krautwald S, Reimann T, Baccarini M . 1995 Mol. Cell Biol. 15: 466–475

  • Camps M, Nichols A, Arkinstall S . 2000 FASEB J. 14: 6–16

  • Chen R-H, Sarnecki C, Blenis J . 1992a Mol. Cell Biol. 12: 915–927

  • Chen J, Martin BL, Brautigan D-L . 1992b Science 257: 1261–1264

  • Chen J, Parsons S, Brautigan D-L . 1994 J. Biol. Chem. 269: 7957–7962

  • Favre B, Turowski P, Hemmings B-A . 1997 J. Biol. Chem. 272: 13856–13863

  • Feldman R-F, Lowy D-R, Vass W-C, Velu T-J . 1989 J. Virol. 63: 5469–5474

  • Feldman RA, Lowy DR, Vass WC . 1990 Oncogene Res. 5: 187–197

  • Gille H, Sharrocks A-D, Shaw P-E . 1992 Nature 358: 414–424

  • Jaworowski A, Christy E, Yusoff P, Byrne R, Hamilton J-A . 1996 Biochem. J. 320: 1011–1016

  • Jaworowski A, Wilson N-J, Christy E, Byrne R, Hamilton J-A . 1999 J. Biol. Chem. 274: 15127–15133

  • Klarlund JK . 1985 Cell 41: 707–717

  • Kolch W . 2000 Biochem. J. 351: 289–305

  • Krautwald S, Baccarini M . 1993 Biochem. Biophys. Res. Commun. 192: 720–727

  • Krautwald S, Büscher D, Dent P, Ruthenberg K, Baccarini M . 1995 Oncogene 10: 1187–1192

  • Lenormand P, Sardet C, Pages G, L'Allemain G, Brunet A, Pouysségur J . 1993 J. Cell Biol. 122: 1079–1088

  • Marais R, Wynne J, Treisman R . 1993 Cell 73: 381–393

  • Marshall C-J . 1995 Cell 80: 179–185

  • Morgan C, Pollard J-W, Stanley E-R . 1987 J. Cell Physiol. 130: 420–427

  • Rovida E, Marra F, Baccarini M, Dello Sbarba P . 2000 Blood 95: 3959–3963

  • Smithgall T-E, Rogers J-A, Peters K-L, Li J, Briggs S-D, Lionberger J-M, Cheng H, Shibata A, Scholtz B, Schreiner S, Dunham N . 1998 Crit. Rev. Oncog. 9: 43–62

  • Valledor A-F, Comalada M, Xaus J, Celada A . 2000 J. Biol. Chem. 275: 7403–7409

  • Wilson N-J, Moss S-T, Csar X-F, Ward A-C, Hamilton J-A . 1999 Biochem. J. 339: 517–524

  • Yeung YG, Berg KL, Pixley FJ, Angeletti RH, Stanley ER . 1992 J. Biol. Chem. 267: 23634–23650

Download references

Acknowledgements

The authors thanks Dr M Balzi and Dr P Cirri for cytofluorimetry. This work was funded by Associazione Italiana per la Ricerca sul Cancro (AIRC), Ministero della Università e della Ricerca Scientifica e Tecnologica and Ente Cassa di Risparmio di Firenze. E Rovida was supported by a fellowship from Fondazione Italiana per la Ricerca sul Cancro (FIRC).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Persio Dello Sbarba.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rovida, E., Baccarini, M., Olivotto, M. et al. Opposite effects of different doses of MCSF on ERK phosphorylation and cell proliferation in macrophages. Oncogene 21, 3670–3676 (2002). https://doi.org/10.1038/sj.onc.1205409

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205409

Keywords

This article is cited by

Search

Quick links